366Jul 21, 2011
Medicare Drug Costs
Witnesses testified about Medicare prescription drug costs and strategies to lower costs through collective bargaining power. In his remarks, Jonathan Blum said that the Congress must pass new ...
1,956Apr 22, 2011
Health Care Costs and Biomedical Innovation
Newt Gingrich and Peter Orszag spoke at a forum on the costs of the health care, the federal health care law enacted the previous year, and its impact on biomedical innovation. The event also ...
674Nov 22, 2010
112th Congress and Health Care
Panelists talked about their opposition to the new health care law and strategies to fight the law short of an unlikely repeal of the measure in the 112th Congress. Jim Capretta, who has called ...
377Mar 29, 2010
Health Care Law and Insurance Programs
Dr. Scott Gottlieb talked about the impact of the health care bill on insurance programs such as Medicaid. He also addressed the bill’s impact both in the short and long terms for ...
178Feb 17, 2009
Book Discussion on Pharmaceutical Price Regulation
As part of a panel discussion on health care costs and the drug industry, John Vernon and Joseph Golec talked about their book Pharmaceutical Price Regulation: Public Perceptions, Economic ...
30Jan 23, 2006
Drug Labeling Changes
Deputy Commissioner Gottlieb talked about a new Food and Drug Administration rule, which takes effect June 30, that mandates that drug labels become easier to read. The rule requires labels ...
103Mar 1, 2005
Prescription Drug Safety
The Senate Health, Education, Labor and Pensions Committee heard testimony from medical experts and consumer advocates on drug safety and the approval process for new drugs. Among the topics ...